Standard titration schedule from trials 12-week escalation protocol: Weeks 1-4: 0.6mg weekly Initiation dose Body adapts to amylin effects Minimal side effects at this level Weight loss begins (modest) Weeks 5-8: 1.2mg weekly First dose increase (doubling) Gastric slowing becomes more noticeable Appetite suppression strengthens Accelerated weight loss Weeks 9-12: 1.8mg weekly Second increase Strong satiety effects More pronounced GI effects possible Approaching maximum efficacy Week 13+: 2.4mg weekly (maintenance) Target therapeutic dose Maximum weight loss velocity Maintained indefinitely Nausea typically resolved by this point (adapted) Why this schedule works: Gradual exposure reduces side effects 4-week intervals allow full adaptation Doubling steps (0.61.22.4) are tolerable Proven in hundreds of patients Balances speed with tolerability Use our peptide calculator and peptide dosing guide at SeekPeptides for precise calculations
Others may need a longer overlap
A molecule that does many things moderately well does not fit a system designed to prove one thing definitively
The pivotal role of central dysfunctional, insulin-resistant adipose tissue to the evolution of advanced fibrosis in patients with T2D and NAFLD, beyond body mass index (BMI) or steatosis, has been well established [5]
MS, Ajmera, R, MS, RD, May 2024 [4] Verywell Health, Is Microdosing Ozempic Safe?, March 2025